Michael Chancellor
Oprichter bij LIPELLA PHARMACEUTICALS INC.
Vermogen: 622 245 $ op 30-04-2024
Profiel
Michael Chancellor is the founder of Cook MyoSite, Inc. (founded in 2002) and Lipella Pharmaceuticals, Inc. (founded in 2005).
At Lipella Pharmaceuticals, Inc., he holds the title of Director & Chief Medical Officer starting in 2008.
Currently, Dr. Chancellor is a Professor at Oakland University (Michigan).
In the past, he worked as a Consultant at Allergan, Inc., Indevus Pharmaceuticals, Inc., Merck & Co., Inc., Astellas US LLC, AstraZeneca LP, and Pfizer Saudi Ltd.
He also served as a Professor at the University of Pittsburgh Medical Center and held the title of Principal at J&J Co. Ltd.
Dr. Chancellor obtained a doctorate degree from The Medical College of Wisconsin, Inc.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 15-03-2024 | 877 637 ( 14.04% ) | 622 245 $ | 30-04-2024 |
Actieve functies van Michael Chancellor
| Bedrijven | Functie | Begin |
|---|---|---|
| LIPELLA PHARMACEUTICALS INC. | Oprichter | 01-01-2005 |
| Oakland University (Michigan) | Corporate Officer/Principal | - |
Eerdere bekende functies van Michael Chancellor
| Bedrijven | Functie | Einde |
|---|---|---|
J&J Co. Ltd.
 J&J Co. Ltd. RestaurantsConsumer Services J&J Co. Ltd. manages restaurants. The private company is based in Kumamoto, Japan. | Corporate Officer/Principal | - |
Astellas US LLC
 Astellas US LLC Pharmaceuticals: MajorHealth Technology Part of Astellas Pharma, Inc., Astellas US LLC is a company that manufactures and markets pharmaceutical products. The company is based in Northbrook, IL. The CEO of the company is Kenji Yasukawa. | Corporate Officer/Principal | - |
| ALLERGAN, INC. | Corporate Officer/Principal | - |
| MERCK & CO., INC. | Corporate Officer/Principal | - |
Indevus Pharmaceuticals, Inc.
 Indevus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Indevus Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the acquisition, development and commercialization of products in the fields of urology, gynecology and infectious diseases. The company markets it's product SANCTURA for the treatment of overactive bladder and has compounds in clinical development including SANCTURA XR, NEBIDO, PRO 2000, IP 751, Pagoclone and Aminocandin. It focuses on the clinical development, regulatory review and commercialization of biopharmaceutical products. Indevus Pharmaceuticals was founded in 1988 and is headquartered in Lexington, MA. | Corporate Officer/Principal | - |
Opleiding van Michael Chancellor
| The Medical College of Wisconsin, Inc. | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| LIPELLA PHARMACEUTICALS INC. | Health Technology |
| Bedrijven in privébezit | 8 |
|---|---|
Allergan, Inc.
 Allergan, Inc. Pharmaceuticals: MajorHealth Technology Allergan, Inc. operated as a global healthcare company. It engaged in the development and commercialization of specialty pharmaceutical, medical device ,and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological, and other specialty markets. The company was founded by Gavin S. Herbert Sr. in 1950 and headquartered in Irvine, CA. | Health Technology |
Indevus Pharmaceuticals, Inc.
Indevus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Indevus Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the acquisition, development and commercialization of products in the fields of urology, gynecology and infectious diseases. The company markets it's product SANCTURA for the treatment of overactive bladder and has compounds in clinical development including SANCTURA XR, NEBIDO, PRO 2000, IP 751, Pagoclone and Aminocandin. It focuses on the clinical development, regulatory review and commercialization of biopharmaceutical products. Indevus Pharmaceuticals was founded in 1988 and is headquartered in Lexington, MA. | Health Technology |
University of Pittsburgh Medical Center
 University of Pittsburgh Medical Center Medical/Nursing ServicesHealth Services University of Pittsburgh Medical Center is a non-profit organization, which engages in the provision of hospital health programs and services. It operates through the following business units: Provider Services, Insurance Services, UPMC International, and UPMC Enterprises. It also develops programs in transplantation, cancer, neurosurgery, psychiatry, orthopedics, and sports medicine. The company was founded in 1893 and is headquartered in Pittsburgh, PA. | Health Services |
Astellas US LLC
Astellas US LLC Pharmaceuticals: MajorHealth Technology Part of Astellas Pharma, Inc., Astellas US LLC is a company that manufactures and markets pharmaceutical products. The company is based in Northbrook, IL. The CEO of the company is Kenji Yasukawa. | Health Technology |
AstraZeneca LP
 AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The company is based in Wilmington, DE. | Health Technology |
J&J Co. Ltd.
J&J Co. Ltd. RestaurantsConsumer Services J&J Co. Ltd. manages restaurants. The private company is based in Kumamoto, Japan. | Consumer Services |
| Pfizer Saudi Ltd. | |
Cook MyoSite, Inc.
 Cook MyoSite, Inc. Packaged SoftwareTechnology Services Cook MyoSite, Inc. is a private company based in Pittsburgh, PA that was founded by Michael Chancellor in 2002. The company is dedicated to the development and commercialization of technology related to the collection, selection, and expansion of human skeletal muscle cells for the treatment of various disorders. Cook MyoSite operates several regulated clinical studies and provides custom services, including modified cell samples to contract manufacturing arrangements, procurement and processing of muscle cells from specific donor populations, custom media formulations, CMO/CDMO arrangements, and QC analytical testing and assay development. The company specializes in muscle cell technology and cell therapy. | Technology Services |
